These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. The use of ultrasound in the evaluation of trophoblastic disease and its response to therapy. Requard CK; Mettler FA Radiology; 1980 May; 135(2):419-222. PubMed ID: 6245429 [TBL] [Abstract][Full Text] [Related]
14. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands. Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723 [TBL] [Abstract][Full Text] [Related]
15. Progesterone in molar vesicle fluid and theca lutein cyst fluid. Dawood MY Obstet Gynecol; 1975 May; 45(5):531-6. PubMed ID: 1124167 [TBL] [Abstract][Full Text] [Related]
16. Ultrasonography in trophoblastic disease. Prando A; Bernardino ME South Med J; 1979 Mar; 72(3):297-9. PubMed ID: 218314 [TBL] [Abstract][Full Text] [Related]
17. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve. Morrow P; Nakamura R; Schlaerth J; Gaddis O; Eddy G Am J Obstet Gynecol; 1985 Apr; 151(7):906-14. PubMed ID: 2580438 [TBL] [Abstract][Full Text] [Related]
18. Current management of complete and partial molar pregnancy. Goldstein DP; Berkowitz RS J Reprod Med; 1994 Mar; 39(3):139-46. PubMed ID: 8035368 [TBL] [Abstract][Full Text] [Related]
19. Persistent trophoblast disease following partial molar pregnancy. Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033 [TBL] [Abstract][Full Text] [Related]
20. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole]. Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]